Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer

PURPOSE: Amrubicin (AMR) is an anticancer drug for patients with relapsed small-cell lung cancer (SCLC). However, the efficacy of AMR in elderly patients with relapsed SCLC after chemotherapy by carboplatin plus etoposide (CE) has not been sufficiently evaluated. PATIENTS AND METHODS: The medical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Igawa, Satoshi, Ono, Taihei, Kasajima, Masashi, Manabe, Hideaki, Fukui, Tomoya, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320750/
https://www.ncbi.nlm.nih.gov/pubmed/32606979
http://dx.doi.org/10.2147/CMAR.S255552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320750/
https://www.ncbi.nlm.nih.gov/pubmed/32606979
http://dx.doi.org/10.2147/CMAR.S255552

Ejemplares similares